Internal Medicine, Clinical Cardiatric Electrophysiology · Provo, UT
NPI
1649491440
Since 2007
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1055 N 500 W, Suite 101
Provo, UT, 84604
Phone (801) 373-4366
Groups this clinician bills Medicare through
Medicare paid, 2024
$418K
7,550 services
Medicare patients, 2024
1,219
Average age 79
Drug cost, 2024
$1.6M
5,164 prescriptions
Company payments, 2025
$978
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David C Wang was code 93296 (external electrocardiographic monitoring), 1,694 times for 606 patients. In total David C Wang billed 7,550 services in 83 codes, and Medicare paid $418K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93296 External Electrocardiographic Monitoring | Office | 1,694 | 606 | $14.31 | $24K |
| 93294 External Electrocardiographic Monitoring | Office | 1,363 | 494 | $20.26 | $28K |
| 99214 Office E&M - Established | Office | 1,021 | 791 | $89.08 | $91K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,012 | 769 | $12.07 | $12K |
| 93280 External Electrocardiographic Monitoring | Office | 362 | 296 | $56.08 | $20K |
| 93295 External Electrocardiographic Monitoring | Office | 313 | 116 | $25.95 | $8,122 |
| 85610 Clinical Chemistry | Office | 190 | 26 | $4.20 | $798 |
| 93656 Comprehensive Electrophysiologic Evaluation | Facility | 97 | 96 | $691.60 | $67K |
| 99204 Office E&M - New | Office | 93 | 93 | $120.73 | $11K |
| 99215 Office E&M - Established | Office | 92 | 88 | $134.53 | $12K |
| 93284 External Electrocardiographic Monitoring | Office | 80 | 53 | $73.62 | $5,890 |
| G0250 Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 77 | 12 | $6.52 | $502 |
| 93793 Care Management/Coordination | Office | 72 | 20 | $7.85 | $565 |
| 93000 Electrocardiogram | Office | 71 | 63 | $10.39 | $737 |
| 99152 Anesthesia | Facility | 67 | 64 | $9.16 | $614 |
By year: 2022 $363K for 5,134 services; 2023 $368K for 5,304 services; 2024 $418K for 7,550 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 190 | 26 | $4.20 | $798 |
| 36415 Venipuncture Blood Collection | 27 | 24 | $8.65 | $234 |
| 80048 Clinical Chemistry | 17 | 14 | $8.29 | $141 |
| 83880 Clinical Chemistry | 17 | 15 | $38.47 | $654 |
Medicare prescription drug claims, 2024
In 2024, the drug David C Wang prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,052 prescriptions and refills. In total David C Wang wrote 5,164 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,052 | 2,052 | 297 | $1.2M |
| Sotalol Sotalol Hcl | 974 | 2,533 | 318 | $20K |
| Flecainide Acetate Generic | 752 | 1,975 | 244 | $28K |
| Metoprolol Succinate Generic | 464 | 1,265 | 154 | $6,971 |
| Amiodarone Hcl Generic | 326 | 781 | 124 | $7,977 |
| Xarelto Rivaroxaban | 317 | 625 | 79 | $341K |
| Metoprolol Tartrate Generic | 217 | 607 | 79 | $2,235 |
| Warfarin Sodium Generic | 124 | 319 | 42 | $1,580 |
| Carvedilol Generic | 115 | 257 | 36 | $681 |
| Propafenone Hcl Generic | 80 | 197 | 25 | $2,787 |
| Lisinopril Generic | 75 | 203 | 25 | $700 |
| Furosemide Generic | 65 | 125 | 26 | $315 |
| Losartan Potassium Generic | 60 | 153 | 21 | $870 |
| Potassium Chloride Generic | 60 | 122 | 29 | $814 |
| Amlodipine Besylate Generic | 52 | 146 | 19 | $466 |
Brand drugs: 1,396 claims; generic drugs: 3,768 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David C Wang $978 ($978 in general payments such as food, travel and fees) from 12 companies. The largest payer was Biosense Webster, Inc. with $246.
| Company | Payments | Amount |
|---|---|---|
| Biosense Webster, Inc. JNJ | 11 | $246 |
| Pfizer Inc. PFE | 11 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $156 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $149 |
| Abbott Laboratories ABT | 2 | $92.96 |
| United Therapeutics Corporation UTHR | 2 | $57.18 |
| BridgeBio Pharma, Inc. BBIO | 1 | $23.06 |
| Merck Sharp & Dohme LLC MRK | 1 | $20.73 |
| Novo Nordisk Inc NVO | 1 | $18.99 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $17.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.